Recently, we invited a couple who we are friends with to stay at our place, as hotel prices are outrageous this time of year ...

We came across a bullish thesis on Viatris Inc. (NASDAQ:VTRS) on ValueInvestorsClub by lightspot. In this article, we will ...

Viatris forecast annual revenue and profit below Wall Street estimates on Thursday, mainly due to a worse-than-feared hit to sales from import restrictions on the drugmaker's manufacturing plant in ...

As low as $9 per dose Active ingredients: Sildenafil, tadalafil, oxytocin How to take: Orally with or without food Form: Quick-dissolving drops FDA information: FDA-approved active ingredients ...

REVEALED: Shop that sold unclaimed winning Lotto ticket for €2 million unveiled The National Lottery has announced the lucky ...

The broad definition of counterfeit is a fake or unauthorised copy of a genuine product, typically medicines, designer ...

With a $430 million buyout of Australia’s Mayne Pharma locked down, Cosette Pharmaceuticals is looking to become a leading ...

Hims & Hers Health Inc. has acquired a California-based manufacturing facility to expand its range of peptide treatments, ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Pharmaceuticals industry for Tuesday, February 25, 2025. Let’s ...

Hims & Hers projects $725M in GLP-1 weight loss revenue for 2025, a 3.2x increase from 2024. Read why I upgrade HIMS stock ...

Hims & Hers reported a double beat in Q4, but faced an 18% stock drop after hours. Read why this drop is a good opportunity ...